These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2361 related items for PubMed ID: 17001224

  • 1. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R, Capestro F, Misiani A, Scipione P, Georgiou D.
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [Abstract] [Full Text] [Related]

  • 2. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR.
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [Abstract] [Full Text] [Related]

  • 3. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR, Multicenter InSync ICD II Study Group.
    Circulation; 2004 Nov 02; 110(18):2864-8. PubMed ID: 15505095
    [Abstract] [Full Text] [Related]

  • 4. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
    Boriani G, Müller CP, Seidl KH, Grove R, Vogt J, Danschel W, Schuchert A, Djiane P, Biffi M, Becker T, Bailleul C, Trappe HJ, Resynchronization for the HemodYnamic Treatment for Heart Failure Management II Investigators.
    Am Heart J; 2006 May 02; 151(5):1050-8. PubMed ID: 16644335
    [Abstract] [Full Text] [Related]

  • 5. Waltz dancing in patients with chronic heart failure: new form of exercise training.
    Belardinelli R, Lacalaprice F, Ventrella C, Volpe L, Faccenda E.
    Circ Heart Fail; 2008 Jul 02; 1(2):107-14. PubMed ID: 19808280
    [Abstract] [Full Text] [Related]

  • 6. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA.
    Curr Opin Anaesthesiol; 2006 Feb 02; 19(1):69-74. PubMed ID: 16547436
    [Abstract] [Full Text] [Related]

  • 7. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL, Dual Chamber and VVI Implantable Defibrillator trial investigators.
    Card Electrophysiol Rev; 2003 Dec 02; 7(4):468-72. PubMed ID: 15071277
    [Abstract] [Full Text] [Related]

  • 8. CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction.
    Aronow WS.
    Geriatrics; 2005 Feb 02; 60(2):24, 26-8. PubMed ID: 15742919
    [Abstract] [Full Text] [Related]

  • 9. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS.
    Am J Cardiol; 2007 Jul 01; 100(1):90-3. PubMed ID: 17599447
    [Abstract] [Full Text] [Related]

  • 10. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP.
    J Cardiovasc Electrophysiol; 2006 May 01; 17(5):486-90. PubMed ID: 16684019
    [Abstract] [Full Text] [Related]

  • 11. Effects of short-term moderate exercise training on sexual function in male patients with chronic stable heart failure.
    Belardinelli R, Lacalaprice F, Faccenda E, Purcaro A, Perna G.
    Int J Cardiol; 2005 May 11; 101(1):83-90. PubMed ID: 15860388
    [Abstract] [Full Text] [Related]

  • 12. [Association of biventricular resynchronizer and implantable cardioverter defibrillator].
    Robledo Nolasco R, Ruiz Soto JC, Méndez Espinoza F, Trujillo Cortés R, Blanco Canto M.
    Arch Cardiol Mex; 2005 May 11; 75 Suppl 3():S3-89-95. PubMed ID: 16366173
    [Abstract] [Full Text] [Related]

  • 13. Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide levels in patients with chronic heart failure.
    Maria Sarullo F, Gristina T, Brusca I, Milia S, Raimondi R, Sajeva M, Maria La Chiusa S, Serio G, Paterna S, Di Pasquale P, Castello A.
    Eur J Cardiovasc Prev Rehabil; 2006 Oct 11; 13(5):812-7. PubMed ID: 17001223
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure.
    Davis DR, Krahn AD, Tang AS, Lemery R, Green MS, Gollob M, Yee R, Skanes AC, Klein GJ, Birnie DH.
    Can J Cardiol; 2005 Apr 11; 21(5):413-7. PubMed ID: 15861258
    [Abstract] [Full Text] [Related]

  • 15. Assessment of resynchronization therapy on functional status and quality of life in patients requiring an implantable defibrillator.
    Pinter A, Mangat I, Korley V, Connolly S, Connors S, Gardner M, Philippon F, Sterns L, Thibault B, Dorian P.
    Pacing Clin Electrophysiol; 2009 Dec 11; 32(12):1509-19. PubMed ID: 19765233
    [Abstract] [Full Text] [Related]

  • 16. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
    Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K, Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators.
    JAMA; 2003 May 28; 289(20):2685-94. PubMed ID: 12771115
    [Abstract] [Full Text] [Related]

  • 17. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
    Ansalone G, Ricci R, Cacciatore G, Santini M.
    Ital Heart J Suppl; 2001 Dec 28; 2(12):1308-14. PubMed ID: 11838353
    [Abstract] [Full Text] [Related]

  • 18. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.
    Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697
    [Abstract] [Full Text] [Related]

  • 19. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI, Theuns DA, van Dalen BM, Vletter WB, Nemes A, Jordaens LJ, Balk AH, Ten Cate FJ, Geleijnse ML.
    Am J Cardiol; 2010 Jan 01; 105(1):105-11. PubMed ID: 20102900
    [Abstract] [Full Text] [Related]

  • 20. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG.
    Eur Heart J; 2007 Jan 01; 28(1):42-51. PubMed ID: 17110403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 119.